| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.051 | 0.8 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.051 | 0.8 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.045 | 0.8 |